In 2002, a long-term study reporting data from 1,848 patients treated with pit-hGH during childhood and early adulthood, showed an increased risk of colorectal cancer and Hodgkin lymphoma (HL) (22). The gene discussed is GH1; the disease is Hodgkins lymphoma.